Rochester, NY 8/24/2009 9:55:47 PM
World Heart Corp. WHRT, World Heart Declares its Approval from U.S. Health Regulators
World Heart Corp. WHRT
World Heart Corp. announces that its shares rose as much as 60% for clinical study of its magnetically levitated implantable heart pump. The company received a conditional approval from U.S. health regulators.
The study of the company's Levacor ventricular assist device has been assigned a CMS category B2 status, which makes insurance reimbursement possible, it said.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
